Form D · Other Investment Fund

GLL Health Sciences Fund Ltd

Po Box 10324 Grand Cayman, E9 · CIK 0001694196

Offering snapshot reported Mar 31, 2026 · SEC filing

Reported sold: $8.25M
Investors reported: 11
Minimum accepted: $250K
First sale: Jan 1, 2017

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$10,588,409 → $8,252,967
Reported investors13 → 11

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 31, 2026	Amendment	$8,252,967	-$2,335,442vs Mar 19, 2025	11	SEC filing
Mar 19, 2025	Amendment	$10,588,409	$179,867vs Mar 7, 2024	13	SEC filing
Mar 7, 2024	Initial	$10,408,542	No comparison	16	SEC filing
Mar 21, 2023	Initial	$9,254,217	No comparison	16	SEC filing
Mar 10, 2022	Initial	$12,278,111	No comparison	16	SEC filing
Mar 8, 2021	Amendment	$15,616,586	$3,616,491vs Mar 30, 2020	17	SEC filing
Mar 30, 2020	Amendment	$12,000,095	$3,069,022vs Mar 27, 2020	15	SEC filing
Mar 27, 2020	Amendment	$8,931,073	$406,354vs Mar 25, 2019	15	SEC filing
Mar 25, 2019	Amendment	$8,524,719	$0vs Mar 21, 2019	15	SEC filing
Mar 21, 2019	Amendment	$8,524,719	-$490,744vs Mar 8, 2018	15	SEC filing
Mar 8, 2018	Amendment	$9,015,463	$5,125,301vs Mar 8, 2017	13	SEC filing
Mar 8, 2017	Amendment	$3,890,162	$229,568vs Jan 19, 2017	8	SEC filing
Jan 19, 2017	Initial	$3,660,594	No comparison	8	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-506936

As of 12/31/25

Source: Form D, filed Mar 31, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

GLL HEALTH SCIENCES FUND LTD

Investment adviser: GLL INVESTORS, LLC

Gross asset value: $8.25M
Beneficial owners: 11
ADV minimum commitment: $250K

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator NAV CONSULTING, INC. OAK BROOK TERRACE, Illinois, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG CAYMAN GEORGETOWN, Cayman Islands

Custodian BMO HARRIS CHICAGO, N.A. CHICAGO, Illinois, United States Related to adviser: No

Prime broker INTERACTIVE BROKERS CHICAGO, Illinois, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG CAYMAN
PCAOB 1323

Filing source

Form ADV 2084273 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-8924422944

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
William Stephen Gilboy	Executive, Promoter
Jason Gilboy	Director, Executive, Promoter
Gll Investors Llc	Promoter
Michael Newlander	Executive, Promoter
Wayne Ross	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

C/Ofive Continents Partners Ltd Anderson Square,4 Th Floor,64 Shedden Rd
Po Box 10324 Grand Cayman, E9, KY1-1003